Business Description
CanSino Biologics Inc
ISIN : CNE100003F01
Share Class Description:
FRA:CJH: Class HCompare
Compare
Traded in other countries / regions
06185.Hong Kong688185.ChinaCJH.GermanyCASBF.USA IPO Date
2019-08-05Description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.61 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.43 | |||||
| Debt-to-EBITDA | -2.54 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.22 | |||||
| Beneish M-Score | -16.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 152.5 | |||||
| 3-Year EBITDA Growth Rate | -57.3 | |||||
| 3-Year EPS without NRI Growth Rate | -44.6 | |||||
| 3-Year FCF Growth Rate | -21.2 | |||||
| 3-Year Book Growth Rate | -7.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 62.96 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.04 | |||||
| 9-Day RSI | 69.35 | |||||
| 14-Day RSI | 64.65 | |||||
| 6-1 Month Momentum % | 68.8 | |||||
| 12-1 Month Momentum % | 55.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.38 | |||||
| Quick Ratio | 2.19 | |||||
| Cash Ratio | 1.85 | |||||
| Days Inventory | 263.25 | |||||
| Days Sales Outstanding | 400.94 | |||||
| Days Payable | 77.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 3.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.65 | |||||
| Operating Margin % | -145.64 | |||||
| Net Margin % | -142.92 | |||||
| FCF Margin % | -108.71 | |||||
| ROE % | -16.02 | |||||
| ROA % | -9.54 | |||||
| ROIC % | -15.92 | |||||
| ROC (Joel Greenblatt) % | -30.2 | |||||
| ROCE % | -12.74 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.8 | |||||
| PB Ratio | 1.56 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| EV-to-EBIT | -12.36 | |||||
| EV-to-EBITDA | -12.36 | |||||
| EV-to-Revenue | 17.47 | |||||
| EV-to-FCF | -16.18 | |||||
| Price-to-Net-Current-Asset-Value | 5.38 | |||||
| Price-to-Net-Cash | 17.3 | |||||
| Earnings Yield (Greenblatt) % | -8.09 | |||||
| FCF Yield % | -5.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CanSino Biologics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 78.133 | ||
| EPS (TTM) (€) | -0.451 | ||
| Beta | 2.29 | ||
| Volatility % | 68.87 | ||
| 14-Day RSI | 64.65 | ||
| 14-Day ATR (€) | 0.144055 | ||
| 20-Day SMA (€) | 3.522 | ||
| 12-1 Month Momentum % | 55.09 | ||
| 52-Week Range (€) | 1.805 - 4.22 | ||
| Shares Outstanding (Mil) | 247.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CanSino Biologics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CanSino Biologics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CanSino Biologics Inc Frequently Asked Questions
What is CanSino Biologics Inc(FRA:CJH)'s stock price today?
The current price of FRA:CJH is €3.98. The 52 week high of FRA:CJH is €4.22 and 52 week low is €1.81.
When is next earnings date of CanSino Biologics Inc(FRA:CJH)?
The next earnings date of CanSino Biologics Inc(FRA:CJH) is 2025-01-30 Est..
Does CanSino Biologics Inc(FRA:CJH) pay dividends? If so, how much?
CanSino Biologics Inc(FRA:CJH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers